Profiel
Richard Murray was the founder of EOS Biotechnology, Inc. founded in 1998 where he held the title of Vice President-Research until 2003.
He is currently a Director at Stellular Bio, Inc. since 2019.
Dr. Murray's former positions include Director, Chief Scientific Officer & EVP at PDL BioPharma, Inc. from 2007 to 2008, Director at Jounce Therapeutics, Inc. in 2023, Senior Vice President-Research & Development at Merck & Co., Inc. from 2009 to 2014, Chief Scientific & Technical Officer & Senior VP at Protein Design Labs, Inc. from 2003 to 2006, and Senior Staff Scientist at DNAX Research, Inc. from 1991 to 1998.
Dr. Murray's education includes an undergraduate degree from the University of Massachusetts, and doctorate degrees from The University of North Carolina at Chapel Hill and The University of North Carolina at Charlotte.
Actieve functies van Richard Murray
| Bedrijven | Functie | Begin |
|---|---|---|
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Directeur/Bestuurslid | 04-06-2019 |
Eerdere bekende functies van Richard Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Algemeen Directeur | 31-03-2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2014 |
| PDL BIOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 05-09-2008 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Hoofd Techniek/Wetenschap/O&O | 10-01-2006 |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Oprichter | 01-04-2003 |
Opleiding van Richard Murray
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
DNAX Research, Inc. | |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Commercial Services |
















